Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
Clinical and Experimental Pharmacology & Physiology
|
November 21, 2008
Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling
Gillian M Mackay, Caroline M Forrest, John Christofides, et al.
The European Journal of Neuroscience
|
November 22, 2011
Altered apoptotic responses in neurons lacking RhoB GTPase
Sara Barberan, Kara McNair, Khalil Iqbal, et al.
Brain Research
|
June 24, 2014
Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway
Mazura Pisar, Caroline M Forrest, Omari S Khalil, et al.
Neurochemistry International
|
September 14, 2016
Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2<sup>+/-</sup> mice, using liquid chromatography-tandem mass spectrometry
Caroline M Forrest, Peter G E Kennedy, Jean Rodgers, et al.
Frontiers in Immunology
|
November 17, 2022
Modulation of immune cell function, IDO expression and kynurenine production by the quorum sensor 2-heptyl-3-hydroxy-4-quinolone (PQS)
Joy Ogbechi, Yi-Shu Huang, Felix I L Clanchy, et al.
Journal of Autoimmunity
|
March 4, 2022
Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression
Felix I L Clanchy, Federica Borghese, Jonas Bystrom, et al.
Behavioural Brain Research
|
July 4, 2012
A novel dihydro-pyrazolo(3,4d)(1,2,4)triazolo(1,5a)pyrimidin-4-one (AJ23) is an antagonist at adenosine A(1) receptors and enhances consolidation of step-down avoidance
Alan L Harvey, Louise C Young, Edgar Kornisiuk, et al.
Journal of Dual Diagnosis
|
December 20, 2023
Integrative Pharmacology in the Treatment of Substance Use Disorders
Jack Donlon, Pooja Kumari, Sajoy P Varghese, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 10, 2026
Potential regulation of kynurenine pathway metabolism by the galantamine-memantine combination in rheumatologic diseases: A hypothesis-driven review
Navya Mathew, Sebin George, Patricia Rejimon, et al.
Journal of Autoimmunity
|
January 25, 2021
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis
Felix I L Clanchy, Federica Borghese, Jonas Bystrom, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
Clinical and Experimental Pharmacology & Physiology
|
November 21, 2008
Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling
Gillian M Mackay, Caroline M Forrest, John Christofides, et al.
The European Journal of Neuroscience
|
November 22, 2011
Altered apoptotic responses in neurons lacking RhoB GTPase
Sara Barberan, Kara McNair, Khalil Iqbal, et al.
Brain Research
|
June 24, 2014
Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway
Mazura Pisar, Caroline M Forrest, Omari S Khalil, et al.
Neurochemistry International
|
September 14, 2016
Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2<sup>+/-</sup> mice, using liquid chromatography-tandem mass spectrometry
Caroline M Forrest, Peter G E Kennedy, Jean Rodgers, et al.
Frontiers in Immunology
|
November 17, 2022
Modulation of immune cell function, IDO expression and kynurenine production by the quorum sensor 2-heptyl-3-hydroxy-4-quinolone (PQS)
Joy Ogbechi, Yi-Shu Huang, Felix I L Clanchy, et al.
Journal of Autoimmunity
|
March 4, 2022
Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression
Felix I L Clanchy, Federica Borghese, Jonas Bystrom, et al.
Behavioural Brain Research
|
July 4, 2012
A novel dihydro-pyrazolo(3,4d)(1,2,4)triazolo(1,5a)pyrimidin-4-one (AJ23) is an antagonist at adenosine A(1) receptors and enhances consolidation of step-down avoidance
Alan L Harvey, Louise C Young, Edgar Kornisiuk, et al.
Journal of Dual Diagnosis
|
December 20, 2023
Integrative Pharmacology in the Treatment of Substance Use Disorders
Jack Donlon, Pooja Kumari, Sajoy P Varghese, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 10, 2026
Potential regulation of kynurenine pathway metabolism by the galantamine-memantine combination in rheumatologic diseases: A hypothesis-driven review
Navya Mathew, Sebin George, Patricia Rejimon, et al.
Journal of Autoimmunity
|
January 25, 2021
TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis
Felix I L Clanchy, Federica Borghese, Jonas Bystrom, et al.
Page
of 11